These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 19217445

  • 1. Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration.
    Surdacki A, Martens-Lobenhoffer J, Wloch A, Gluszko P, Rakowski T, Dubiel JS, Bode-Böger SM.
    Metabolism; 2009 Mar; 58(3):316-8. PubMed ID: 19217445
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R.
    Minerva Anestesiol; 2010 May; 76(5):325-33. PubMed ID: 20395894
    [Abstract] [Full Text] [Related]

  • 4. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S, Ueda S, Okuda S.
    Med Hypotheses; 2007 May; 69(4):922-4. PubMed ID: 17368960
    [Abstract] [Full Text] [Related]

  • 5. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
    Krzyzanowska K, Mittermayer F, Shnawa N, Hofer M, Schnabler J, Etmüller Y, Kapiotis S, Wolzt M, Schernthaner G.
    Diabet Med; 2007 Jan; 24(1):81-6. PubMed ID: 17227328
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
    Chandrasekharan UM, Wang Z, Wu Y, Wilson Tang WH, Hazen SL, Wang S, Elaine Husni M.
    Arthritis Res Ther; 2018 Jun 08; 20(1):123. PubMed ID: 29884228
    [Abstract] [Full Text] [Related]

  • 9. The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolism.
    Haider DG, Bucek RA, Reiter M, Minar E, Hron G, Kyrle PA, Mittermayer F, Wolzt M.
    Transl Res; 2006 Jul 08; 148(1):26-9. PubMed ID: 16887495
    [Abstract] [Full Text] [Related]

  • 10. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
    Kurz K, Teerlink T, Sarcletti M, Weiss G, Zangerle R, Fuchs D.
    Antivir Ther; 2012 Jul 08; 17(6):1021-7. PubMed ID: 22892398
    [Abstract] [Full Text] [Related]

  • 11. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity.
    De Rycke L, Nicholas AP, Cantaert T, Kruithof E, Echols JD, Vandekerckhove B, Veys EM, De Keyser F, Baeten D.
    Arthritis Rheum; 2005 Aug 08; 52(8):2323-30. PubMed ID: 16052592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma asymmetric dimethylarginine and retinal vessel diameters in middle-aged men.
    Hemminki V, Laakso J, Kähönen M, Turjanmaa V, Uusitalo H, Lehtimäki T, Ruokonen I, Laaksonen R, Huhtala H, Päivä H.
    Metabolism; 2007 Oct 08; 56(10):1305-10. PubMed ID: 17884437
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Asymmetric dimethylarginine: metabolism, arginine paradox, pathophysiology].
    Gilinskiĭ MA.
    Usp Fiziol Nauk; 2007 Oct 08; 38(3):21-39. PubMed ID: 17977229
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
    Nagasaka H, Tsukahara H, Yorifuji T, Miida T, Murayama K, Tsuruoka T, Takatani T, Kanazawa M, Kobayashi K, Okano Y, Takayanagi M.
    Metabolism; 2009 Mar 08; 58(3):278-82. PubMed ID: 19217439
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis.
    Sandoo A, Dimitroulas T, Toms TE, Hodson J, Veldhuijzen van Zanten JJ, Smith JP, Kitas GD.
    Clin Biochem; 2012 Nov 08; 45(16-17):1399-403. PubMed ID: 22820438
    [Abstract] [Full Text] [Related]

  • 19. Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects.
    Paroni R, Fermo I, Fiorina P, Cighetti G.
    Amino Acids; 2005 Jun 08; 28(4):389-94. PubMed ID: 15827687
    [Abstract] [Full Text] [Related]

  • 20. Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease.
    Murr C, Meinitzer A, Grammer T, Schroecksnadel K, Böhm BO, März W, Fuchs D.
    Scand J Immunol; 2009 Jul 08; 70(1):63-7. PubMed ID: 19522769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.